Parkside Financial Bank & Trust Pacira Bio Sciences, Inc. Transaction History
Parkside Financial Bank & Trust
- $702 Million
- Q3 2024
A detailed history of Parkside Financial Bank & Trust transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Parkside Financial Bank & Trust holds 18 shares of PCRX stock, worth $473. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18
Previous 5
260.0%
Holding current value
$473
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding PCRX
# of Institutions
254Shares Held
48.5MCall Options Held
429KPut Options Held
391K-
Black Rock Inc. New York, NY8.01MShares$211 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.3MShares$140 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA3.26MShares$85.9 Million0.15% of portfolio
-
State Street Corp Boston, MA2.01MShares$53 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.98MShares$52.1 Million0.05% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.21B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...